EPA guidance on the early detection of clinical high risk states of psychoses

European Psychiatry : the Journal of the Association of European Psychiatrists
Frauke Schultze-LutterJoachim Klosterkötter

Abstract

The aim of this guidance paper of the European Psychiatric Association is to provide evidence-based recommendations on the early detection of a clinical high risk (CHR) for psychosis in patients with mental problems. To this aim, we conducted a meta-analysis of studies reporting on conversion rates to psychosis in non-overlapping samples meeting any at least any one of the main CHR criteria: ultra-high risk (UHR) and/or basic symptoms criteria. Further, effects of potential moderators (different UHR criteria definitions, single UHR criteria and age) on conversion rates were examined. Conversion rates in the identified 42 samples with altogether more than 4000 CHR patients who had mainly been identified by UHR criteria and/or the basic symptom criterion 'cognitive disturbances' (COGDIS) showed considerable heterogeneity. While UHR criteria and COGDIS were related to similar conversion rates until 2-year follow-up, conversion rates of COGDIS were significantly higher thereafter. Differences in onset and frequency requirements of symptomatic UHR criteria or in their different consideration of functional decline, substance use and co-morbidity did not seem to impact on conversion rates. The 'genetic risk and functional decline' UHR...Continue Reading

References

Mar 1, 1992·Schizophrenia Research·H HäfnerW van der Heiden
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Oct 1, 1995·Journal of the American Academy of Child and Adolescent Psychiatry·J Alaghband-RadJ L Rapoport
Jan 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·H HäfnerA Riecher-Rössler
Oct 1, 1996·The Australian and New Zealand Journal of Psychiatry·A R Yung, P D McGorry
Feb 15, 2001·Archives of General Psychiatry·J KlosterkötterF Schultze-Lutter
May 17, 2002·Journal of the American Academy of Child and Adolescent Psychiatry·John L Schaeffer, Randal G Ross
Dec 31, 2002·Schizophrenia Research·Alison R YungPatrick D McGorry
Jun 15, 2004·Health Technology Assessment : HTA·P WhitingJ Kleijnen
Jul 21, 2004·Molecular Psychiatry·P J Harrison, D R Weinberger
Oct 2, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Anthony P MorrisonRichard P Bentall
Jun 1, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Wulf RösslerAnita Riecher-Rössler
Jun 2, 2005·The British Journal of Psychiatry : the Journal of Mental Science·Richard GaterNorman Sartorius
Jul 22, 2005·Journal of the American Academy of Child and Adolescent Psychiatry·Trevor BallageerRaj Haricharan
Aug 2, 2005·The British Journal of Psychiatry. Supplement·J Bertolote, P McGorry
Aug 12, 2005·Journal of Child and Adolescent Psychopharmacology·Stefanie A Hlastala, Jon McClellan
Dec 14, 2005·The Australian and New Zealand Journal of Psychiatry·Alison R YungJoe Buckby
Jan 1, 1987·Journal of Personality Assessment·T M Osberg
May 11, 2006·The Australian and New Zealand Journal of Psychiatry·May M L LamEric Y H Chen
Aug 19, 2006·Schizophrenia Research·Randal G RossHope Tregellas
Jan 3, 2007·Archives of General Psychiatry·Jonna PeräläJouko Lönnqvist
Feb 10, 2007·Psychological Medicine·Anne ThorupMerete Nordentoft
Aug 21, 2007·Comprehensive Psychiatry·Frauke Schultze-LutterF Markus Leweke
Jan 19, 2008·The British Journal of Psychiatry. Supplement·S RuhrmannUNKNOWN LIPS study group
Jan 9, 2008·Archives of General Psychiatry·Tyrone D CannonRobert Heinssen
Feb 19, 2008·Schizophrenia Research·D J WalderE F Walker
Apr 9, 2008·Fortschritte der Neurologie-Psychiatrie·A Riecher-RösslerR-D Stieglitz
May 24, 2008·Schizophrenia Research·UNKNOWN European Network of Schizophrenia Networks for the Study of Gene-Environment Interactions
Jun 27, 2008·Schizophrenia Bulletin·Frauke Schultze-LutterJoachim Klosterkötter
Aug 25, 2009·Lancet·Jim van Os, Shitij Kapur
Sep 8, 2009·Biological Psychiatry·Anita Riecher-RösslerRolf-Dieter Stieglitz
Sep 30, 2009·Schizophrenia Research·Serafín Lemos-GiráldezJose Angel Ortega-Ferrández
Mar 5, 2010·Acta Psychiatrica Scandinavica·A BechdolfA R Yung
Jul 16, 2010·Psychiatry Research·Ana González-PintoCelso Arango

❮ Previous
Next ❯

Citations

Feb 10, 2016·Frontiers in Psychiatry·Frauke Schultze-LutterPeter J Uhlhaas
Feb 18, 2016·Neural Plasticity·Joseph Gonzalez-HeydrichFrank H Duffy
Mar 5, 2016·Nature Reviews. Drug Discovery·Mark J MillanDaniel Weinberger
Nov 4, 2015·Schizophrenia Research·Marco ArmandoFrauke Schultze-Lutter
Mar 10, 2016·Harvard Review of Psychiatry·Kristen A WoodberryLarry J Seidman
Jul 15, 2015·Social Psychiatry and Psychiatric Epidemiology·Frauke Schultze-LutterJoachim Klosterkötter
Sep 27, 2015·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Paolo Fusar-PoliPhilip McGuire
Jun 5, 2015·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Benno G SchimmelmannFrauke Schultze-Lutter
Apr 26, 2016·Early Intervention in Psychiatry·Magdalena Kotlicka-AntczakAgnieszka Pawełczyk
Jun 7, 2016·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Anita Riecher-Rössler, Erich Studerus
Aug 16, 2016·Schizophrenia Research·Daniel MamahDavid M Ndetei
Aug 25, 2016·La Presse médicale·Vincent LaprevoteAnita Riecher-Rössler
Sep 10, 2016·Journal of Behavior Therapy and Experimental Psychiatry·Sarah Eisenacher, Mathias Zink
Oct 8, 2016·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Maude SchneiderStephan Eliez
Oct 9, 2016·Psychiatry Research·Sibylle MetzlerAnastasia Theodoridou
Jan 27, 2017·Early Intervention in Psychiatry·Anna ÄrmänenMaija Lindgren
Feb 18, 2017·Current Opinion in Psychiatry·Anita Riecher-Rössler, Erich Studerus
Feb 24, 2017·Current Opinion in Psychiatry·Lily VanAnne S Bassett
May 5, 2017·Praxis der Kinderpsychologie und Kinderpsychiatrie·Frauke Schultze-LutterBenno G Schimmelmann
Feb 28, 2018·Psychiatry and Clinical Neurosciences·Naohisa TsujinoMasafumi Mizuno
Dec 19, 2017·Frontiers in Psychiatry·Stefanie J SchmidtBarnaby Nelson
Nov 9, 2017·Early Intervention in Psychiatry·Ana BarajasSusana Ochoa
Sep 16, 2017·European Child & Adolescent Psychiatry·Jordina TorInmaculada Baeza
Jul 19, 2018·Early Intervention in Psychiatry·David PeraltaAnita Riecher-Rössler
Jan 18, 2018·Psychological Medicine·Maria Carmela PadulaStephan Eliez
Jan 3, 2019·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Chantal MichelFrauke Schultze-Lutter
Jan 29, 2019·Early Intervention in Psychiatry·Theresa K HaidlKai Vogeley
Jan 6, 2018·Journal of Psychiatric Practice·Othman SentissiMicaela Santos Brosch
Jul 13, 2018·Clinical Practice and Epidemiology in Mental Health : CP & EMH·Antonio PretiMauro G Carta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.